Modeling ADC payload biology using Simulated Cells – Update Poster
ADCs represent a new era of targeted cancer therapy with 15 approved drugs. However, over 100 discontinued ADC programs and a similar number of active clinical trials highlight the difficulties of identifying the optimal combination of antibody, target, payload, linker, drug-antibody ratio and indication. Understanding mechanisms and factors contributing to different levels… read more